Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 3Withdrawn 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Breast Neoplasms 2Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 12Oxaliplatin 11Leucovorin 10Irinotecan 7Capecitabine 7regorafenib 4Radiotherapy 4Bevacizumab 4aflibercept 2Reverse Transcriptase Polymerase Chain Reaction 2Radiation 2Neoadjuvant Therapy 2Biopsy 2tucatinib 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1sulindac sulfone 1sargramostim 1pembrolizumab 1lonafarnib 1irofulven 1infigratinib 1dehydroftorafur 1balstilimab 1XELOX 1Trifluridine 1Trastuzumab 1Transplantation 1Sunitinib 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Rectal Neoplasms × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT01403103 2014-01-17

Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00960427 2013-04-16

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Barbara Ann Karmanos Cancer Institute

Phase 1 Withdrawn
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡